ReviewVascular specialist international2026
Infection after Endovascular Repair of Complex Aortic and Thoracoabdominal Aneurysms with Fenestrated and Branched Devices: A Systematic Descriptive Review.
Review in Vascular specialist international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endograft infection after fenestrated or branched endovascular aortic repair (F/BEVAR) is an uncommon yet serious complication due to the involvement of the visceral branches and the complexity of the required treatment. This systematic review aimed to descriptively synthesize reported cases of infection after F/BEVAR, with an emphasis on clinical presentation, microbiology, associated aortoenteric fistulas (AEFs), management strategies, and reported outcomes. A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, with MEDLINE, Scopus, and the Cochrane Library searched up to September 14, 2025; eligible reports included case reports and series describing F/BEVAR-related infections. Eleven studies encompassing 26 patients were identified. The weighted mean patient age was approximately 73 years, and 77% of patients were male. The weighted mean interval from repair to infection was approximately 20 months. Microbiological findings were heterogeneous, with both Gram-negative and Gram-positive organisms and several polymicrobial infections reported. AEFs were confirmed in at least 8/26 (31%) patients. Surgical explantation with reconstruction was performed in 12/26 patients (46%), conservative therapy in 12/26 (46%), and graft-preserving procedures in 2/26 (8%). The overall 30-day mortality rate was 4/26 (15%): 3/12 after graft explantation and reconstruction, 1/12 after conservative treatment, and 0/2 after graft-preserving procedures. Among the 22 patients who survived 30 days, 18 (82%) were alive at the last reported follow-up: 9/9 after graft explantation and reconstruction, 7/11 after conservative treatment, and 2/2 after graft-preserving procedures. Infection after F/BEVAR requires individualized management and has been reported to have a heterogeneous clinical presentation, microbiological findings, and treatment strategies. Given the limited evidence base, consisting primarily of case reports and small case series, these findings should be interpreted descriptively. Multicenter collaboration and standardized reporting are needed to better characterize this complication and inform future management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.